LFMT vs Placebo in New Biologic Start for Ulcerative Colitis

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 3, 2022

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions

Ulcerative Colitis

Interventions

DRUG

Lyophilized fecal microbiota (LFMT)

vedolizumab or ustekinumab + FMT vs placebo

OTHER

Placebo

Trial Locations (1)

RECRUITING

University of Alberta Hospital, Edmonton

All Listed Sponsors

lead

University of Alberta

OTHER